Navigation Links
Sanofi-aventis Announces a Good Third Quarter Performance; Increase in 2007 full-year earnings growth guidance
Date:10/31/2007
0 patients. The new development program in diabetes, essentially as an add-on to the main existing treatments (metformin, sulfonylurea and insulin), includes a comparative study with sitagliptin, the most recently approved treatment. Submission in type 2 diabetes is expected in 2009, while submission of a fixed rimonabant/metformin combination is expected in 2010.
Xyzal(R), a new once-daily prescription oral antihistamine used to treat internal and external allergies and chronic idiopathic urticaria, was launched in the United States by sanofi-aventis and UCB at the start of October. The product, which has been shown to be highly effective in the treatment of allergy symptoms, is indicated for adults and for children aged six and over.
Worldwide presence(1) of Plavix(R) / Iscover(R)
Change on Change on
a a
2007 comparable 2007 comparable
euro million Q3 basis 9 months basis
Europe 450 +6.6% 1,350 +5.4%
United States 797 +126.4% 2,159 +23.9%
Other countries 213 +23.8% 601 +21.2%
TOTAL 1,460 +54.3% 4,110 +16.8%
On June 19, 2007, the U.S. District Court for the Southern District of
New York upheld the validity and enforceability of the U.S. patent covering
clopidogrel bisulfate, the active ingredient of Plavix(R), and issued a
permanent injunction enjoining Apotex from marketing its generic
clopidogrel bisulfate in the United States prior to the expiration of the
patent. Apotex launched a generic clopidogrel bisulfate in August 2006,
following which the U.S. District Court for the Southern District of New
York awarded sanofi- aventis a temporary injunction on August 31,
'/>"/>
| SOURCE sanofi-aventis Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. FDA Gives Green Signal To Sanofi-Aventis SAs Cancer Drug Taxotere
2. Sanofi-Aventis sets the ball rolling for trials of H7N1 bird flu vaccine
3. Sanofi-Aventis Allows Thais To Make Plavix
4. PM announces a new health care order for India
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
(Date:5/20/2013)... 20, 2013 In order to prepare for ... wellness team from DrSmartphoneMD launched an article series to raise ... The series launched with the precautions that need ... the DrSmartphoneMD program are not one of the 3.5 million ... more than 90% of all skin cancer cases are associated ...
(Date:5/20/2013)... Angeles, CA (PRWEB) May 20, 2013 ... just been released to the public creating a ... gain access to this elite business training. WealthSpringMarketing.com's ... course as well as an exclusive bonus. , ... for providing elite business training to individuals serious ...
(Date:5/20/2013)... 2013 Parker Waichman LLP, a national ... injured by defective drugs, has filed a lawsuit on ... use of the diabetes drug medication Actos (pioglitazone) ... April 30, 2013, in the U.S. District Court for ... it is one of thousands of cases pending in ...
(Date:5/20/2013)... West Palm Beach, FL (PRWEB) May 20, 2013 ... Schwartz is honored to be recognized as a “Top Doc” ... of The Palm Beacher Magazine. , The Palm Beacher ... published a list of “Top Docs” in the May/June 2013 ... specialties. Featuring the best restaurants and dining, events, things to ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Mirena ... in the multidistrict litigation recently established in U.S. District ... reports. According to court records, the litigation’s first ... time appointments to Plaintiff’s leadership positions were discussed. ... in the Southern District of New York, all of ...
Breaking Medicine News(10 mins):Health News:Combat Skin Cancer In Summer Months 2Health News:Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com 2Health News:Taking Actos for Two Years Caused Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP on Behalf of South Dakota Man 2Health News:Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 2Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 3[0] Combat Skin Cancer In Summer Months[0] Eben Pagan's Accelerate: Review and Bonus Released By WealthSpringMarketing.com[0] Taking Actos for Two Years Caused Bladder Cancer, Alleges Lawsuit Filed by Parker Waichman LLP on Behalf of South Dakota Man[0] Dr. Schwartz Named “Top Doc” by The Palm Beacher Magazine[0] Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation
... advertises during shows watched by typical U.S. teens, analysis ... TV shows that attract a significant proportion of teenage ... for alcohol, new research has found. , Using Nielsen ... for alcohol that aired on cable TV from 2001 ...
... ... , with the influx of new patients entering the healthcare system under Obama,s proposed ... ... Journal of General Internal Medicine, healthcare planners projected that physician surpluses of both U.S. ...
... ... ready to heat and eat meals, are applauding the recent TIME magazine cover story that ... properly balanced meals. , ... VA (PRWEB) August 29, 2009 -- Officials at Diet-to-Go, a national leader in deliciously healthy, ...
... untreated Ugandans infected with type D were affected, study ... subtype of HIV a person has may determine their ... report. , Cognitive difficulties, even dementia, are a common ... Africa, researchers led by Dr. Ned Sacktor noted that ...
... , , , , ... 1 , , HARRISBURG, Pa., Aug. 28 ... people who live or work within a 10-mile radius of Pennsylvania,s five nuclear ... tablets that were distributed previously by the commonwealth will expire on Aug. 31 ...
... help physicians predict a patient,s risk of dying from chronic ... assess the severity of a patient,s illness to determine the ... bronchitis, is a major public health problem and it is ... study of the ADO index is published in the August ...
Cached Medicine News:Health News:Alcohol Ads on Cable TV Reach Young Audiences 2Health News:Alcohol Ads on Cable TV Reach Young Audiences 3Health News:Foreign Physician Growth in the U.S. and the Impact on Medical Credentialing 2Health News:Foreign Physician Growth in the U.S. and the Impact on Medical Credentialing 3Health News:Diet-to-Go Asks: Isn't it TIME You Listened to the Facts About Weight Loss? 2Health News:Diet-to-Go Asks: Isn't it TIME You Listened to the Facts About Weight Loss? 3Health News:Pennsylvania Health Department Distributing Potassium Iodide to People Living, Working Near Nuclear Power Plants 2Health News:Pennsylvania Health Department Distributing Potassium Iodide to People Living, Working Near Nuclear Power Plants 3Health News:New tool to predict the risk of death in COPD may help physicians to individualize treatment 2Alcohol Ads on Cable TV Reach Young AudiencesForeign Physician Growth in the U.S. and the Impact on Medical CredentialingDiet-to-Go Asks: Isn't it TIME You Listened to the Facts About Weight Loss?Dementia More Likely With One Subtype of HIVPennsylvania Health Department Distributing Potassium Iodide to People Living, Working Near Nuclear Power PlantsNew tool to predict the risk of death in COPD may help physicians to individualize treatment
(Date:5/19/2013)... OAKLAND, Calif. , May 20, 2013 Whole-cell ... than acellular pertussis vaccines during a large recent outbreak, ... Pediatrics. Whole-cell pertussis vaccines, also called DTwP, ... associated with safety concerns that ultimately led to the ... DTaP. By the late 1990s, the United ...
(Date:5/18/2013)... ORLANDO, Fla. , May 18, 2013 ... and are considered the most sensitive method for ... completely effective in preventing cancer cases 3 . EndoChoice ... its new Fuse™ system significantly improves the accuracy of ... missed by colonoscopists. EndoChoice will be discussing these clinical ...
(Date:5/18/2013)... , May 18, 2013 Faruqi & ... is investigating potential securities fraud at AVEO Pharmaceuticals, ... (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) ... its executives violated federal securities laws by issuing ... Phase III drug trials for Tivopath (tivozanib) (titled ...
Breaking Medicine Technology:Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2[0] Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak[0] New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy[0] Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm
... RA Signs and Symptoms Compared to Placebo, ... (Nasdaq: TRBN ) today announced preliminary ... double-blind, placebo-controlled, multicenter,clinical trial of its TRU-015 ... indicated that Trubion,s TRU-015 product candidate, at,well-tolerated ...
... Calif., Sept. 10 Peregrine,Pharmaceuticals, Inc. (Nasdaq: ... antibodies for the treatment of cancer and,hepatitis C ... submitted a,clinical protocol with the Drug Controller General ... safety and efficacy trial of bavituximab in combination,with ...
Cached Medicine Technology:Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 2Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 3Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 4Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 5Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 2Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 3Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 4... of three software components that comprise ... ,Three software components comprise the SmartPill ... software, SmartPill Data Receiver software and ... are integrated and indispensable parts of ...
... Analysis for POLYGRAM NET™ works with the ... analyze multichannel EGG signals. The EGG analysis ... by performing an automatic electrode impedance check ... beginning of a recording. If the electrode ...
... the foundation and supporting framework for ... extremely versatile software supports the reporting, ... the GI diagnostic testing procedures including ... ambulatory pH testing, esophageal manometry, bile ...
Symbia T, a TruePoint SPECTCT system, combines a dual-detector variable angle gamma camera with a CT scanner optimized for rapid, accurate attenuation correction of the nuclear data....
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |